SPONSOR
Abiomed Inc.
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Heart FailureCardiogenic ShockReduced Ejection Fraction Heart FailureAMI Cardiogenic Shock
Abiomed Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Heart Failure, Cardiogenic Shock, Reduced Ejection Fraction Heart Failure, AMI Cardiogenic Shock.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Abiomed Inc.
How many clinical trials has Abiomed Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Abiomed Inc., of which 2 are actively recruiting participants. These trials cover conditions including Heart Failure, Cardiogenic Shock, Reduced Ejection Fraction Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Abiomed Inc. research focus on?
Abiomed Inc. clinical trials span Heart Failure, Cardiogenic Shock, Reduced Ejection Fraction Heart Failure, AMI Cardiogenic Shock. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Abiomed Inc. clinical trial?
To participate in a Abiomed Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Abiomed Inc. trials with current recruitment status updated daily.
Clinical Trials by Abiomed Inc.
NCT06965504
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Heart Failure
NCT06964685
Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology